EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity

Hamdi Nsairat iD, Zainab Lafi iD, Bassam M Abualsoud iD, Belal O Al-Najjar iD, Ali Al-Samydai iD, Ghaleb Ali Oriquat, Walhan Alshaer iD, Abed Alqader Ibrahim iD, Anthony L Dellinger iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.042534 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Hamdi Nsairat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacological and Diagnostic Research Center, Faculty of Pharmacy Al-Ahliyya Amman University Amman Jordan. Hauptthemen laut MEDLINE: Ascorbic Acid, Doxorubicin, Antibiotics, Antineoplastic, Antioxidants. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin is used and highly effective chemotherapeutic agent; however, its clinical utility remains limited by dose‐dependent cardiotoxicity, presenting a significant challenge in cancer management. Growing preclinical research and clinical evidence suggest that the antioxidant vitamin C (ascorbic acid) may confer cardioprotective effects against doxorubicin‐induced cardiotoxicity. In this review, both preclinical and clinical research has been synthesized to assess the potential role of vitamin C in mitigating doxorubicin‐induced cardiotoxicity. Preclinical data have routinely indicated that vitamin C can reduce oxidative stress, preserve mitochondrial function, and modulate proinflammatory cytokine levels. Additionally, animal models have demonstrated promising results in maintaining cardiomyocyte structural integrity. In this capacity, vitamin C may be an effective adjunctive therapeutic for attenuating cardiac injury. Conversely, the clinical data remain variable, with emerging evidence supporting the notion that vitamin C can serve as a safe adjunct that preserves cardiac function during anthracycline therapy. Further investigation is warranted to optimize dosing, timing, and delivery routes and better elucidate the exact molecular mechanisms of these protective effects. This review emphasizes key molecular mechanisms, such as oxidative and nitrosative stress, mitochondrial dysfunction, and inflammatory signaling, in the myocardium, and examines the role of vitamin C supplementation, alone or in combination with doxorubicin, on myocardial damage markers and cardiomyocyte viability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ascorbic AcidDoxorubicinAntibiotics, AntineoplasticAntioxidantsMyocytes, CardiacHeart DiseasesCardiotonic AgentsHumansCardiotoxicityAnimalsOxidative StressMitochondria, Heart

Stichwörter der Autor:innen

cardioprotectiondoxorubicin‐induced cardiotoxicityoxidative stressreactive oxygen speciesvitamin C

Substanzen

Ascorbic AcidDoxorubicinAntibiotics, AntineoplasticAntioxidantsCardiotonic Agents

Autor:innen und Institutionen

  • Pharmacological and Diagnostic Research Center, Faculty of Pharmacy Al-Ahliyya Amman University Amman Jordan.
  • Pharmacological and Diagnostic Research Center, Faculty of Allied Medical Sciences Al-Ahliyya Amman University Amman Jordan.
  • Cell Therapy Center The University of Jordan Amman Jordan.
  • Pharmacological and Diagnostic Research Center Al-Ahliyya Amman University Amman Jordan.
  • Department of Nanoscience, Joint School of Nanoscience and Nanoengineering University of North Carolina at Greensboro Greensboro NC USA.
  • AT Research Partners Burlington NC USA.

ORCID-Profile: Hamdi Nsairat, Zainab Lafi, Bassam M Abualsoud, Belal O Al-Najjar, Ali Al-Samydai, Walhan Alshaer, Abed Alqader Ibrahim, Anthony L Dellinger

Zitieren

APA

Nsairat, H., Lafi, Z., Abualsoud, B. M., Al-Najjar, B. O., Al-Samydai, A., Oriquat, G. A., Alshaer, W., Alqader Ibrahim, A., & Dellinger, A. L. (2025). Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042534

Vancouver

Nsairat H, Lafi Z, Abualsoud BM, Al-Najjar BO, Al-Samydai A, Oriquat GA, et al. Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042534

BibTeX
@article{Nsairat2025,
  author = {Nsairat, Hamdi and Lafi, Zainab and Abualsoud, Bassam M and Al-Najjar, Belal O and Al-Samydai, Ali and Oriquat, Ghaleb Ali and Alshaer, Walhan and Alqader Ibrahim, Abed and Dellinger, Anthony L},
  title = {Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.042534}
}
Kostenlos starten →